FENO testing is the first non-invasive, easy-to-use method of measuring bronchial inflammation. Before FENO testing became available, the only methods of assessing inflammation were more invasive procedures like sputum induction, bronchial lavage and lung biopsies, which were neither routine, nor cost effective and in addition unpleasant for the patient.
• Fast and simple test
• Non-invasive procedure
• Improves asthma control [Jones 2001, Pijnenburg 2005]
• Reduces the use of unnecessary corticosteroids[Smith 2005]
• Predicts asthma relapse [Pijnenburg 2005]
• Fast, simple, non-invasive procedure
• Immediate results
• Improves diagnostic capabilities [Malmberg 2003, Smith 2004]
• Anticipates steroid responsiveness [Smith 2005, Zeiger 2006]
• Identifies non-compliance issues [Beck-Ripp 2002, Delgado-Corcoran 2004]
• Helps titrate corticosteroid doses for optimal control [Pijnenburg 2005, Cowan 2005]
• Predicts asthma relapse [Pijnenburg 2005]
• Alerts to loss of symptom control [Jones 2001]
• Improves asthma management (Jones 2001, Pijnenburg 2005]
• Improves patient outcomes (Pijnenburg 2005]
• Builds expertise in inflammatory diseases of the airways through data collection
• Reduces costs
• Enhances the reputation of the clinic through its expertise in using the newest and most efficient asthma management tool